HEADER CELL CYCLE 12-JAN-24 8ROZ TITLE CRYO-EM STRUCTURE OF CDK2-CYCLIN A IN COMPLEX WITH CDC25A COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: HUMAN CYCLIN DEPENDANT PROTEIN KINASE 2 (CDK2) COMPND 8 PHOSPHORYLATED AT TYR15 AND THR160; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLIN-A2; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: CYCLIN-A; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: BOVINE CYCLIN A2; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: M-PHASE INDUCER PHOSPHATASE 1; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: DUAL SPECIFICITY PHOSPHATASE CDC25A; COMPND 19 EC: 3.1.3.48; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: M-PHASE INDUCER PHOSPHATASE 1 (CDC25A) CATALYTIC COMPND 22 DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX6P1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 12 ORGANISM_COMMON: CATTLE; SOURCE 13 ORGANISM_TAXID: 9913; SOURCE 14 GENE: CCNA2; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VARIANT: ROSETTA PLYSS; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PGEX6P1; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: CDC25A; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 25 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 26 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS CELL-CYCLE, CDK, PHOSPHATASE, CANCER, CELL CYCLE EXPDTA ELECTRON MICROSCOPY AUTHOR R.J.ROWLAND,M.E.M.NOBLE,J.A.ENDICOTT REVDAT 3 13-NOV-24 8ROZ 1 REMARK REVDAT 2 28-AUG-24 8ROZ 1 JRNL REVDAT 1 29-MAY-24 8ROZ 0 JRNL AUTH R.J.ROWLAND,S.KOROLCHUK,M.SALAMINA,N.J.TATUM,J.R.AULT, JRNL AUTH 2 S.HART,J.P.TURKENBURG,J.N.BLAZA,M.E.M.NOBLE,J.A.ENDICOTT JRNL TITL CRYO-EM STRUCTURE OF THE CDK2-CYCLIN A-CDC25A COMPLEX. JRNL REF NAT COMMUN V. 15 6807 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 39122719 JRNL DOI 10.1038/S41467-024-51135-W REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : TOPAZ, EPU, CRYOSPARC, UCSF CHIMERAX, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : 144.000 REMARK 3 REMARK 3 FITTING PROCEDURE : A MODEL WAS GENERATED USING MODELANGELO. REMARK 3 INITIAL LOCAL FITTING WAS PERFORMED IN CHIMERX FOLLOWED BY REAL REMARK 3 SPACE REFINEMENT IN PHENIX AND MANUAL FITTING IN COOT. REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.700 REMARK 3 NUMBER OF PARTICLES : 670830 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8ROZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1292135863. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TRIMERIC COMPLEX OF CDK2-CYCLIN REMARK 245 A-CDC25A REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.80 REMARK 245 SAMPLE SUPPORT DETAILS : GRIDS WERE GLOW DISCHARGED FOR REMARK 245 1MIN AT 20 MAMP/0.26 MBAR REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 600.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 150000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 LEU A 296 CG CD1 CD2 REMARK 470 ARG A 297 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 298 CG CD1 CD2 REMARK 470 LYS C 523 CG CD CE NZ REMARK 470 LEU C 524 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG C 437 CE MET C 489 1.66 REMARK 500 CZ ARG C 437 CE MET C 489 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 14 59.99 -92.89 REMARK 500 SER A 94 30.48 -96.76 REMARK 500 ASP A 127 46.71 -140.75 REMARK 500 TYR A 159 -164.32 -109.50 REMARK 500 VAL A 163 -66.83 -122.19 REMARK 500 SER A 181 -159.80 -147.24 REMARK 500 PRO A 238 1.31 -65.76 REMARK 500 VAL B 173 70.62 52.76 REMARK 500 ASP B 281 32.75 70.83 REMARK 500 GLN B 368 -169.16 -79.35 REMARK 500 HIS C 490 52.76 -91.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-19408 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF CDK2-CYCLIN A IN COMPLEX WITH CDC25A DBREF 8ROZ A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 8ROZ B 170 430 UNP P30274 CCNA2_BOVIN 170 430 DBREF 8ROZ C 338 524 UNP P30304 MPIP1_HUMAN 338 524 SEQADV 8ROZ MET B 168 UNP P30274 INITIATING METHIONINE SEQADV 8ROZ GLY B 169 UNP P30274 EXPRESSION TAG SEQADV 8ROZ SER C 335 UNP P30304 EXPRESSION TAG SEQADV 8ROZ MET C 336 UNP P30304 EXPRESSION TAG SEQADV 8ROZ VAL C 337 UNP P30304 EXPRESSION TAG SEQADV 8ROZ SER C 431 UNP P30304 CYS 431 ENGINEERED MUTATION SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR PTR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 263 MET GLY VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE SEQRES 2 B 263 HIS THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO SEQRES 3 B 263 LYS VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SEQRES 4 B 263 SER MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL SEQRES 5 B 263 GLY GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU SEQRES 6 B 263 ALA VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER SEQRES 7 B 263 VAL LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA SEQRES 8 B 263 MET LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO SEQRES 9 B 263 GLU VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR SEQRES 10 B 263 THR LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU SEQRES 11 B 263 LYS VAL LEU ALA PHE ASP LEU ALA ALA PRO THR ILE ASN SEQRES 12 B 263 GLN PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA SEQRES 13 B 263 ASN CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU SEQRES 14 B 263 LEU SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU SEQRES 15 B 263 PRO SER VAL ILE ALA ALA ALA ALA PHE HIS LEU ALA LEU SEQRES 16 B 263 TYR THR VAL THR GLY GLN SER TRP PRO GLU SER LEU VAL SEQRES 17 B 263 GLN LYS THR GLY TYR THR LEU GLU THR LEU LYS PRO CYS SEQRES 18 B 263 LEU LEU ASP LEU HIS GLN THR TYR LEU ARG ALA PRO GLN SEQRES 19 B 263 HIS ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER SEQRES 20 B 263 LYS TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR SEQRES 21 B 263 LEU ASN VAL SEQRES 1 C 190 SER MET VAL ILE GLY ASP PHE SER LYS GLY TYR LEU PHE SEQRES 2 C 190 HIS THR VAL ALA GLY LYS HIS GLN ASP LEU LYS TYR ILE SEQRES 3 C 190 SER PRO GLU ILE MET ALA SER VAL LEU ASN GLY LYS PHE SEQRES 4 C 190 ALA ASN LEU ILE LYS GLU PHE VAL ILE ILE ASP CYS ARG SEQRES 5 C 190 TYR PRO TYR GLU TYR GLU GLY GLY HIS ILE LYS GLY ALA SEQRES 6 C 190 VAL ASN LEU HIS MET GLU GLU GLU VAL GLU ASP PHE LEU SEQRES 7 C 190 LEU LYS LYS PRO ILE VAL PRO THR ASP GLY LYS ARG VAL SEQRES 8 C 190 ILE VAL VAL PHE HIS SER GLU PHE SER SER GLU ARG GLY SEQRES 9 C 190 PRO ARG MET CYS ARG TYR VAL ARG GLU ARG ASP ARG LEU SEQRES 10 C 190 GLY ASN GLU TYR PRO LYS LEU HIS TYR PRO GLU LEU TYR SEQRES 11 C 190 VAL LEU LYS GLY GLY TYR LYS GLU PHE PHE MET LYS CYS SEQRES 12 C 190 GLN SER TYR CYS GLU PRO PRO SER TYR ARG PRO MET HIS SEQRES 13 C 190 HIS GLU ASP PHE LYS GLU ASP LEU LYS LYS PHE ARG THR SEQRES 14 C 190 LYS SER ARG THR TRP ALA GLY GLU LYS SER LYS ARG GLU SEQRES 15 C 190 MET TYR SER ARG LEU LYS LYS LEU MODRES 8ROZ PTR A 15 TYR MODIFIED RESIDUE MODRES 8ROZ TPO A 160 THR MODIFIED RESIDUE HET PTR A 15 16 HET TPO A 160 11 HETNAM PTR O-PHOSPHOTYROSINE HETNAM TPO PHOSPHOTHREONINE HETSYN PTR PHOSPHONOTYROSINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 PTR C9 H12 N O6 P FORMUL 1 TPO C4 H10 N O6 P HELIX 1 AA1 PRO A 45 LYS A 56 1 12 HELIX 2 AA2 LEU A 87 SER A 94 1 8 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 ASP A 145 ALA A 149 5 5 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 ARG A 199 1 18 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 ASP A 247 VAL A 252 1 6 HELIX 10 AB1 ASP A 256 LEU A 267 1 12 HELIX 11 AB2 SER A 276 LEU A 281 1 6 HELIX 12 AB3 HIS A 283 GLN A 287 5 5 HELIX 13 AB4 MET B 168 VAL B 173 5 6 HELIX 14 AB5 TYR B 176 CYS B 191 1 16 HELIX 15 AB6 GLY B 196 LYS B 200 5 5 HELIX 16 AB7 THR B 205 TYR B 223 1 19 HELIX 17 AB8 GLN B 226 MET B 244 1 19 HELIX 18 AB9 LYS B 250 GLU B 267 1 18 HELIX 19 AC1 GLU B 272 ASP B 281 1 10 HELIX 20 AC2 THR B 285 ALA B 301 1 17 HELIX 21 AC3 THR B 308 PHE B 317 1 10 HELIX 22 AC4 LEU B 318 GLN B 320 5 3 HELIX 23 AC5 ASN B 324 ASP B 341 1 18 HELIX 24 AC6 ASP B 341 LEU B 346 1 6 HELIX 25 AC7 LEU B 349 THR B 366 1 18 HELIX 26 AC8 PRO B 371 GLY B 379 1 9 HELIX 27 AC9 LEU B 385 ARG B 398 1 14 HELIX 28 AD1 GLN B 405 TYR B 411 1 7 HELIX 29 AD2 LYS B 412 HIS B 417 5 6 HELIX 30 AD3 GLY B 418 LEU B 422 5 5 HELIX 31 AD4 SER C 361 ASN C 370 1 10 HELIX 32 AD5 TYR C 387 GLU C 392 1 6 HELIX 33 AD6 MET C 404 LEU C 413 1 10 HELIX 34 AD7 GLU C 436 GLY C 452 1 17 HELIX 35 AD8 GLY C 468 CYS C 477 1 10 HELIX 36 AD9 PHE C 494 LYS C 522 1 29 SHEET 1 AA1 5 PHE A 4 ILE A 10 0 SHEET 2 AA1 5 VAL A 18 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O LEU A 32 N TYR A 19 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O PHE A 80 N ALA A 31 SHEET 5 AA1 5 LEU A 66 HIS A 71 -1 N ASP A 68 O VAL A 79 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 AA4 5 TYR C 359 ILE C 360 0 SHEET 2 AA4 5 GLU C 462 LEU C 466 1 O VAL C 465 N ILE C 360 SHEET 3 AA4 5 ARG C 424 HIS C 430 1 N PHE C 429 O TYR C 464 SHEET 4 AA4 5 ILE C 377 ASP C 384 1 N VAL C 381 O VAL C 428 SHEET 5 AA4 5 VAL C 400 ASN C 401 1 O VAL C 400 N ASP C 384 LINK C THR A 14 N PTR A 15 1555 1555 1.33 LINK C PTR A 15 N GLY A 16 1555 1555 1.33 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.33 CISPEP 1 VAL A 154 PRO A 155 0 0.10 CISPEP 2 GLN B 321 PRO B 322 0 -0.71 CISPEP 3 ASP B 343 PRO B 344 0 0.13 CISPEP 4 TYR C 455 PRO C 456 0 -11.65 CISPEP 5 GLU C 482 PRO C 483 0 -1.70 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000